Arix Taps Australia's 'Undervalued' Pharmaxis As First VIPE, More Planned

 
• By Sten Stovall
  
Incubator Fund Arix takes an 11% stake and board seat at Pharmaxis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business